More Than Just Keeping Up With the Dow Joneses
The short-sightedness of investors creates an embedded incentive for market participants, who control an enormous amount of capital, to favor stocks that are expected to do well in the shorter run.
Wall Street is inherently short-termist. Not because it is dumb. Quite the contrary, some of the brightest minds in the country labor in the investment industry. However, as the mutual fund industry has grown, the desire for short-term gratification has altered the focus, turning an investment business into a marketing one.
There is nothing wrong with marketing; some of my good friends are marketers. A marketer's job is to discover what customers want and to try to meet that need. Unfortunately, the investing public needs instant gratification. They want to keep up with the (Dow) Joneses, and they want their fund to "beat" the other funds and comparable indices on a short-term basis - quarterly and annually. That is not what investing is about; it is about reaching long-term financial goals without taking unnecessary risks.
Mutual funds' individual inflows and outflows are driven by how they rank against their peers on a short-term basis. Many mutual fund managers and analysts' compensation packages are structured to meet goals (maximize inflows, minimize outflows) with great emphasis on short-term performance, creating faulty incentives. Hedge fund managers face an even trickier dilemma; they need to show absolute positive returns month after month.
Fund managers are often forced into making a short-term decision they know is the wrong strategy for the long run, based on the knowledge that their job may not survive the short run. For instance, Oakmark fund manager Robert Sanborn was replaced in 2000 when his value-oriented fund had underperformed the market and lost $7 bln in asset outflows.
His decision not to jump on the dot com wagon and to stick to what he was hired to do, value investing (not speculating), was vindicated several months later when the NASDAQ collapsed and value stocks came back into vogue - for what has so far been a run of more than six years. Unfortunately, his tenure did not survive the short run.
Investors chase last year's performers, and that is the reason equity fund investors, according to a study by Dalbar, a financial services market research firm, have historically underperformed the mutual funds they have invested in by a huge margin. Media hype does not help either: every January last year's mutual fund "winners" are paraded through year-end publications. Don't blame the media, they publish what people want to read.
The short-sightedness of investors creates an embedded incentive for market participants, who control an enormous amount of capital, to favor stocks that are expected to do well in the shorter run. They will sell, or avoid, stocks that could have a great risk/reward profile in the long run but whose immediate future is ambiguous. For those who can stomach the short-run and have a longer time horizon than several quarters, this creates an opportunity for time arbitrage.
Time arbitrage is often created when a stock is sold off on missing its "guidance" (which does not have to be by much), fails to "meet" Wall Street's earnings estimates, or simply has a short-term stumble (which will happen to any company, it is just a matter of time).
We do not live in a linear world and should not expect linear performance from the companies we invest in. In spite of Wall Street's perception, these short-term events have little or no impact on the long-term stream of company cash flows. Thus they have little, if any, impact on a company's actual value.
However, Wall Street will dump a stock, often driving it far below its intrinsic value, if it stands between a fund manager and his annual bonus (or him keeping his job).
Quest Diagnostics (DGX) is a perfect example of time arbitrage in the making. The stock has been knocked down from $64 to $49 [as of May 3] owing to the loss of the United Healthcare contract. As dramatic as it sounds, UnitedHealth Group (UNH) accounted for only 7 percent of Quest Diagnostic's revenue, and had little impact on the company's long-term fundamentals. I believe the stock is worth considerably more, north of $80. Here is the rub: earnings will not grow for a year, something Wall Street cannot digest.
Time arbitrage is not a risk-less opportunity. Odds are, if you have the contrarian mindset, are not afraid of being on the lonely side of the fence, or owning a stock that may end up being "dead money" for a while; you have a great opportunity to take advantage of Wall Street's habitual and recurring short-termism.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter